Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

NEUROSANT THERAPEUTICS LLC

Group Recipients By:

Issue Date FY Summary


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Award Number	Award Title	Award Code	Budget Year	OPDIV	Action Date	Action Amount

Issue Date FY: 2025 ( Subtotal = $195,944 )
2025	2025	NEUROSANT THERAPEUTICS LLC	540 AVENIDA VERDE	SAN MARCOS	CA	92069-1386	SAN DIEGO	USA	R21HD115076	Therapeutics that Correct the Underlying Cause of Smith-Magenis Syndrome (SMS)	000	2	NIH	7/29/2025	$195,944
															Subtotal = $195,944

Issue Date FY: 2024 ( Subtotal = $189,056 )
2024	2024	NEUROSANT THERAPEUTICS LLC	540 AVENIDA VERDE	SAN MARCOS	CA	92069-1386	SAN DIEGO	USA	R21HD115076	Therapeutics that Correct the Underlying Cause of Smith-Magenis Syndrome (SMS)	000	1	NIH	7/10/2024	$189,056
															Subtotal = $189,056

Grand Total All Awards = $385,000

Top